生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Smith+Nephew
rolls out RENASYS EDGE wound therapy system in US
2024-04-02
·
NS Medical Devices
并购
RENASYS EDGE is a lightweight, compact system designed to be easily carried or worn, features a discreet canister, and operates without noise, to treat patients suffering from
chronic wounds
and living at home The RENASYS EDGE system is designed for patients suffering from
chronic wounds
. (Credit:
Smith+Nephew
) skype tellinguk Arbitrary Ltd 20 High Street Clapham MK41 6EG ©Smith&Nephew British medical technology company
Smith+Nephew
has introduced its RENASYS EDGE negative pressure wound therapy (NPWT) system in the US, for treating
chronic wounds
. RENASYS EDGE is a lightweight, compact system that can be easily carried or worn, features a discreet canister, and operates without noise. The system is designed for patients suffering from
chronic wounds
and living at home. As part of the commercial launch,
Smith+Nephew
announced two new national distribution partners for the RENASYS EDGE System,
SunMED Medical Solutions
and First Nation Group. The new partners will help the medical device maker distribute its new technology to more patients and support its growing negative pressure wound therapy business.
Smith+Nephew
NPWT vice president and general manager Laura Ackerman said: “When designing the RENASYS EDGE System we kept patients and their needs in the forefront of our minds. It’s the very definition of our purpose – Life Unlimited – allowing patients to continue with their daily lives while receiving prescribed negative pressure wound therapy. “And now with SunMED in the commercial healthcare market and First Nation Group supporting our veterans, RENASYS EDGE will be able to create a lasting impact on the way patients experience the benefit of negative pressure wound therapy in the comfort of their home.” According to
Smith+Nephew
,
chronic wounds
have a huge impact on a patient’s life, with 68% often becoming self-conscious of their wound and many becoming isolated. The need to carry a bulky, noisy medical device that draws attention to their condition increases their discomfort. Its easy-to-use RENASYS EDGE system comes with a user-friendly interface and provides step-by-step guidance on therapy applications. Also, the system provides technical support with just one click during set-up with the near-field communication feature, said the medical device company. In November last year,
Smith+Nephew
agreed to acquire Israeli medical device manufacturer
CartiHeal
for an initial consideration of $180m plus additional payments of up to $150m.
更多内容,
请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
Smith + Nephew, Inc.
Sunmed Medical Solutions
CartiHeal Ltd.
适应症
创伤和损伤
靶点
-
药物
-
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务